DM
GILD icon

Diversified Management’s Gilead Sciences GILD Stock Holding History

Diversified Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$444K Buy
2,979
+109
+4% +$15.3K 0.08% 170
2026
Q2 		$363K Sell
2,870
-413
-13% -$54.4K 0.08% 124
2026
Q1 		$458K Buy
3,283
+783
+31% +$110K 0.08% 190
2025
Q4 		$307K Buy
+2,500
New +$304K 0.07% 134

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Diversified Management's GILD Position: Q3 2026 in Review

Diversified Management increased its Gilead Sciences (GILD) stake by 3.8% in Q3 2026, buying an estimated $15.3K and bringing the position to 2,979 shares worth $444K. The position accounts for 0.08% of the portfolio, ranked #170.

Diversified Management first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $458K in Q1 2026. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Diversified Management held 2,979 shares of Gilead Sciences worth $444K as of Q3 2026.
  • Diversified Management bought 109 Gilead Sciences shares in Q3 2026, an estimated $15.3K.
  • Gilead Sciences made up 0.08% of Diversified Management's portfolio in Q3 2026, its #170 holding.
  • Diversified Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • Diversified Management's Gilead Sciences position peaked at $458K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Diversified Management's 13F filing for Q3 2026, filed 8 Oct 2026.